Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 1/20 | 0.64 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | CTSS | P25774 | 1/20 | 0.55 |
| ▸ | CTSK | P43235 | 1/20 | 0.55 |
| ▸ | PAM | P19021 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 1/20 | 0.51 |
| ▸ | CA3 | P07451 | 1/20 | 0.51 |
| ▸ | CA4 | P22748 | 1/20 | 0.51 |
| ▸ | CA6 | P23280 | 1/20 | 0.51 |
| ▸ | CA5A | P35218 | 1/20 | 0.51 |
| ▸ | CA7 | P43166 | 1/20 | 0.51 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.51 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.51 |
| ▸ | CA9 | Q16790 | 1/20 | 0.51 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.51 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.51 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12889163 | 1.00 | TACR1 (0.64) | TACR1POLBCTSSCTSKPAM | |
| SCHEMBL1235531 | 1.00 | TACR1 (0.64) | TACR1POLBCTSSCTSKPAM | |
| Propanol SCHEMBL9182309 | 0.96 | TACR1 (0.60) | TACR1POLBCTSSCTSKPAM | |
| SCHEMBL9486892 | 0.92 | TACR1 (0.61) | TACR1POLBCTSSCTSKPAM | |
| SCHEMBL9488064 | 0.92 | TACR1 (0.61) | TACR1POLBCTSSCTSKPAM | |
| SCHEMBL11676193 | 0.89 | TACR1 (0.58) | TACR1POLBCTSSCTSKPAM | |
| SCHEMBL11676190 | 0.89 | TACR1 (0.58) | TACR1POLBCTSSCTSKPAM | |
| SCHEMBL242242 | 0.88 | TACR1 (0.71) | TACR1POLBCTSSCTSKPAM | |
| SCHEMBL242241 | 0.88 | TACR1 (0.71) | TACR1POLBCTSSCTSKPAM | |
| SCHEMBL3046854 | 0.87 | TACR1 (0.52) | TACR1ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006119283-A2 | ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE | YU RUEY J (US) | 2006-11-09 | — | — | WO | claimed |
| US-20060251597-A1 | ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE | YU RUEY J | 2006-11-09 | — | — | US | claimed |
| EP-3721943-A1 | LIPIDS, LIPID COMPOSITIONS AND METHODS OF USING THEM | Novartis AG (CH) | 2020-10-14 | — | — | EP | disclosed |
| US-20180051271-A1 | NON-AQUEOUS ENZYME-POLYMER CONJUGATE SOLUTIONS AND RELATED METHODS | CARNEGIE MELLON UNIVERSITY | 2018-02-22 | — | — | US | disclosed |
| EP-3256168-A1 | NON-AQUEOUS ENZYME-POLYMER CONJUGATE SOLUTIONS AND RELATED METHODS | Carnegie Mellon University (US) | 2017-12-20 | — | — | EP | disclosed |
| WO-2016130677-A1 | NON-AQUEOUS ENZYME-POLYMER CONJUGATE SOLUTIONS AND RELATED METHODS | CARNEGIE MELLON UNIVERSITY (US) | 2016-08-18 | — | — | WO | disclosed |
| US-9301923-B2 | Lipids, lipid compositions, and methods of using them | NOVARTIS AG (CH) | 2016-04-05 | — | — | US | disclosed |
| US-9301923-B2 | Lipids, lipid compositions, and methods of using them | NOVARTIS AG (CH) | 2016-04-05 | — | — | US | disclosed |
| US-20140309277-A1 | LIPIDS, LIPID COMPOSITIONS, AND METHODS OF USING THEM | NOVARTIS AG (CH) | 2014-10-16 | — | — | US | disclosed |
| US-20140309277-A1 | LIPIDS, LIPID COMPOSITIONS, AND METHODS OF USING THEM | NOVARTIS AG (CH) | 2014-10-16 | — | — | US | disclosed |
| US-20130224826-A1 | BIOACTIVE COMPOSITION INCLUDING STABILIZED PROTEIN AND PROCESS FOR PRODUCING THE SAME | TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) | 2013-08-29 | — | — | US | disclosed |
| EP-1025066-A2 | MOLECULAR COMPOUNDS HAVING COMPLEMENTARY SURFACES TO TARGETS | Alnis, LLC (US) | 2000-08-09 | — | — | EP | disclosed |
| WO-2000017333-A8 | MICROBEAD IMMOBILIZATION OF ENZYMES | FMC CORP (US) | 2000-07-27 | — | — | WO | disclosed |
| WO-2000017333-A1 | MICROBEAD IMMOBILIZATION OF ENZYMES | FMC CORPORATION (US) | 2000-03-30 | — | — | WO | disclosed |
| WO-2000017333-A1 | MICROBEAD IMMOBILIZATION OF ENZYMES | FMC CORPORATION (US) | 2000-03-30 | — | — | WO | disclosed |
| WO-1999019276-A2 | MOLECULAR COMPOUNDS HAVING COMPLEMENTARY SURFACES TO TARGETS | ALNIS, LLC (US) | 1999-04-22 | — | — | WO | disclosed |
| US-5719039-A | FOR PEPTIDE SYNTHESIS FROM ACYL DONORS AND NUCLEOPHILES | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 1998-02-17 | — | — | US | disclosed |
| WO-1996027373-A1 | USE OF N-SUBSTITUTED L-PHENYLALANINE ESTERS FOR THE TREATMENT OF ECZEMA | STIEFEL LABORATORIES, INC. (US) | 1996-09-12 | — | — | WO | disclosed |
| EP-0253199-A2 | Process for the biocatalytic conversion of substrates having a poor solubility in aqueous solutions | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-01-20 | — | — | EP | disclosed |
| EP-0244711-A1 | Process for the preparation of amino acid esters | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-11-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140309277-A1 | LIPIDS, LIPID COMPOSITIONS, AND METHODS OF USING THEM | SGMS1, SGMS2, LIPC | TACR1 1227/4885POLB 4742/4885CTSS 1060/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.